Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (40)

2008

  1. Detection of gene amplification and copy gains in brain metastases of solid tumors using quantitative real-time polymerase chain reaction

    Cancer Genetics and Cytogenetics

  2. Mutational analysis of the CITED4 gene in glioblastomas

    Cancer Genetics and Cytogenetics

2007

  1. DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood

    Neoplasma, Vol. 54, Núm. 2, pp. 123-126

  2. DNA methylation pattern in 16 tumor-related genes in schwannomas

    Cancer Genetics and Cytogenetics

  3. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors

    Cancer Genetics and Cytogenetics, Vol. 173, Núm. 1, pp. 63-67

  4. Gene dosage and mutational analyses of EGFR in oligodendrogliomas

    International Journal of Oncology, Vol. 30, Núm. 1, pp. 209-215

  5. Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma

    Cancer Genetics and Cytogenetics

2006

  1. Promoter CpG methylation of multiple genes in pituitary adenomas: Frequent involvement of Caspase-8

    Oncology Reports, Vol. 15, Núm. 2, pp. 443-448

2005

  1. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas

    Genes Chromosomes and Cancer, Vol. 42, Núm. 3, pp. 314-319

  2. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations

    Neuropathology and Applied Neurobiology, Vol. 31, Núm. 4, pp. 384-394

  3. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.

    International journal of molecular medicine, Vol. 16, Núm. 4, pp. 771-774

  4. Mutational study of the 1p located genes p18ink4c, Patched-2, RIZ1 and KIF1B in oligodendrogliomas

    Oncology Reports, Vol. 13, Núm. 3, pp. 539-542

  5. No evidence of INI1hSNF5 (SMARCB1) and PARVG point mutations in oligodendroglial neoplasms

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 2, pp. 169-173

  6. Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas

    American Journal of Clinical Pathology, Vol. 123, Núm. 6, pp. 900-906

  7. Real-time quantitative PCR analysis of regions involved in gene amplification reveals gene overdose in low-grade astrocytic gliomas

    Diagnostic Molecular Pathology, Vol. 14, Núm. 4, pp. 224-229

2004

  1. Aberrant CpG island methylation of multiple genes in ependymal tumors

    Journal of Neuro-Oncology, Vol. 67, Núm. 1-2, pp. 159-165

  2. Análisis mutacional de los genes de la familia TP53 en oligodendrogliomas

    Clinical and Translational Oncology, Vol. 6, Núm. 1, pp. 37-40

  3. DNA methylation of multiple promoter-associated CpG islands in meningiomas: Relationship with the allelic status at 1p and 22q

    Acta Neuropathologica, Vol. 108, Núm. 5, pp. 413-421

  4. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma

    Oncology Reports, Vol. 12, Núm. 3, pp. 663-666

  5. Hypermethylation of the DNA repair gene MGMT: Association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 554, Núm. 1-2, pp. 23-32